Jeff Chiprin - 03 Mar 2026 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role: Chief Commercial Officer
Signature: /s/ Jeff Chiprin
Issuer symbol: IRMD
Transactions as of: 03 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2026, 14:44:02 UTC
Previous filing: 12 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Chiprin Jeff	Chief Commercial Officer	C/O IRADIMED CORPORATION, 12705 INGENUITY DRIVE, ORLANDO	/s/ Jeff Chiprin	05 Mar 2026	0002047489

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IRMD	Restricted Stock Units	Award		+1,150		$0.000000^*	1,150	03 Mar 2026	Common Stock	1,150		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2	The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 7, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.